ANIP — ANI Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.92bn
- $2.21bn
- $883.37m
ANI Pharmaceuticals Inc expected to post earnings of 86 cents a share - Earnings Preview
Brief: ANI Pharmaceuticals-Unit Got Into Deal With 1540700 Ontario Limited For Purchase and Sale Of Co's Oakville, Ontario Former Manufacturing Facility
Brief: ANI Pharmaceuticals Announces Launch Of Pentoxifylline Extended-Release Tablets, USP
Brief: ANI Pharmaceuticals Announces FDA Approval And Launch Of Indomethacin Oral Suspension, USP
Brief: ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results And Raises 2023 Guidance
Brief: ANI Pharmaceuticals Q3 Adjusted EPS USD 1.27
Brief: ANI Pharmaceuticals Announces The FDA Approval And Launch Of Estradiol Gel, 0.1%
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Heritage Insurance, Mirati
ANI Pharmaceuticals climbs on annual forecast raise, Q2 results beat
ANI Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: ANI Pharmaceuticals Q2 Operating Income USD 12.402 Million
ANI Pharmaceuticals Inc expected to post earnings of 68 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Verizon Communications, Home Depot, Catalent
U.S. STOCKS ON THE MOVE-Oramed, Fisker, Blue Bird
ANI Pharmaceuticals rises on FDA approval for generics
Brief: ANI Pharmaceuticals Announces FDA Approval And Commercialization Of Two ANDAs With CGT Exclusivity
U.S. STOCKS ON THE MOVE-DXP Enterprises, Holley, Augmedix
U.S. STOCKS ON THE MOVE-Arlo Technologies, Old Republic, Clearmind Medicine
Brief: Ani Pharmaceuticals Announces Pricing Of $75 Million Public Offering Of Common Stock